物理封装和化疗:用于抑制瘤的协同水凝策略
Yajie Gong1, Weiguang Yuan2,3, Siyu Liu1
1Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150086, China.
Advanced healthcare materials
|May 5, 2025
概括
一种新的混合凝,结合了脱细胞化奥门水凝和酸,有效地抑制了固体瘤. 当加载多克索鲁比辛 (DOX-Mix Gel) 时,它通过持续的药物释放和向治疗来增强抗瘤结果.
科学领域:
- 生物材料科学 生物材料科学
- 在瘤学瘤学.
- 药物输送系统 药物输送系统
背景情况:
- 传统化疗因系统性毒性而面临局限性.
- 开发局部化和向性的癌症疗法至关重要.
- 混合水凝提供了改善药物输送和疗效的潜力.
研究的目的:
- 开发和评估一种用于固体瘤治疗的新型混合水凝 (Mix Gel).
- 为了研究含多克索鲁比的混合凝 (DOX-Mix Gel) 的协同抗瘤作用.
- 评估Mix Gel作为一种微创癌症治疗策略的潜力.
主要方法:
- 使用脱细胞化奥门水凝和酸制造混合凝.
- 将多克索鲁比辛纳入混合凝,形成DOX-Mix凝.
- 在体内评估DOX-Mix Gel在抑制瘤,诱导亡和血管干扰方面的有效性.
主要成果:
- 周注射Mix Gel可以实现瘤封装和抑制生长.
- 通过持续释放多克索鲁比,DOX-Mix Gel 显示出协同作用的抗瘤作用.
- 在体内研究表明,DOX-Mix Gel显著抑制瘤扩散,增加亡,破坏瘤血液供应,并诱导代谢应激.
结论:
- 混合凝是一种生物相容且机械稳定的混合水凝.
- DOX-Mix 凝为增强固体瘤治疗提供了一个有希望的策略,可降低全身毒性.
- 混合凝的可扩展性和最小侵入性使其成为癌症治疗的临床相关方法.
相关概念视频
Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K


